approval
saveMEPRON (ATOVAQUONE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalMar 23, 2026 · 198d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalMar 20, 2026 · 201d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalJul 18, 2019 · 2638d ago
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalFeb 22, 2019 · 2784d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalFeb 22, 2019 · 2784d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalJun 4, 2015 · 4143d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalMar 1, 2013 · 4968d ago
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalFeb 27, 2013 · 4970d ago
same company · ±60 days · 4
- approvalFLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approvalAug 23, 2017
- approvalSUMATRIPTAN SUCCINATE: IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 14, 2017
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN) — FDA approvalDec 14, 2017
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalDec 14, 2017
comments(0)
5-min edit window · permanent after that